Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/24085
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorTobón Orozco, Ángela María-
dc.contributor.authorArango Arteaga, Myrtha-
dc.contributor.authorFernández, Darío-
dc.contributor.authorRestrepo Moreno, Ángela-
dc.date.accessioned2021-11-14T12:15:16Z-
dc.date.available2021-11-14T12:15:16Z-
dc.date.issued2003-
dc.identifier.issn1058-4838-
dc.identifier.urihttp://hdl.handle.net/10495/24085-
dc.description.abstractABSTRACT: We describe the case of a diabetic patient who developed a severe invasive fungal infection due to Rhizopus species postoperatively after a dual heart/kidney transplantation with subsequent intensive immunosuppressive therapy. No improvement was noted with amphotericin B (deoxycholate) therapy, but salvage treatment with the new azole antifungal posaconazole (200 mg orally 4 times daily) resulted in dramatic clinical improvement as early as 1 week after the initiation of therapy that continued through 23 weeks of treatment, with marked clinical, mycological, and radiological improvements and no adverse events.spa
dc.format.extent4spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherUniversity of Chicago Pressspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleMucormycosis (Zygomycosis) in a heart-Kidney trasplant recipient : recovery after posaconazole therapyspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupMicología Médica y Experimentalspa
dc.identifier.doi10.1086/375075-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1537-6591-
oaire.citationtitleClinical Infectious Diseasesspa
oaire.citationstartpage1488spa
oaire.citationendpage1491spa
oaire.citationvolume36spa
oaire.citationissue11spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeChicago, Estados Unidosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTCASOspa
dc.type.localReporte de casospa
dc.subject.decsDiabetes mellitus-
dc.subject.decsTrasplante de Riñón-
dc.subject.decsKidney Transplantation-
dc.subject.decsZigomicosis-
dc.subject.decsZygomycosis-
dc.subject.decsAnfotericina B-
dc.subject.decsAmphotericin B-
dc.subject.decsMucormicosis-
dc.subject.decsMucormycosis-
dc.subject.decsRhizopus-
dc.subject.decsÁcido Desoxicólico-
dc.subject.decsDeoxycholic Acid-
dc.subject.decsReceptores de Trasplantes-
dc.subject.decsTransplant Recipients-
dc.subject.decsRiñón-
dc.subject.decsKidney-
dc.subject.decsCorazón-
dc.subject.decsHeart-
dc.subject.lembInmunosupresión-
dc.subject.lembInmunosuppression-
dc.description.researchgroupidCOL0013709spa
dc.relation.ispartofjournalabbrevClin. Infect. Dis.spa
Aparece en las colecciones: Artículos de Revista en Microbiología

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
RestrepoAngela_2003_MucormycosisTransplantPosaconazole.pdfReporte de caso120.54 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons